ARCHIVES

New Treatment Modalities For Endometrial Cancer

This article is from The Cancer Letter archive.

Vol. 27 No. 3 | March 26, 2004

Download PDF Visit The Full Archive

Related Articles

Garb Denies He, Panel Said Contract Should Be Primary Funding Mechanism

March 17, 1978

“Absurd” Budget Cuts Would Devastate Cancer Program, Slash NCI Funds By $125 Million

December 6, 1974

New Mexico, Missouri, Columbia Next for Review As comprehensive Centers; UCLA Decision In October

September 17, 1976

In Brief: Abeloff, Fisher Lead ASCO; Henney Replaces Antman On Govt. Relations; Ultmann Retires

May 31, 1991

In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List

December 2, 1983

Fisher Committee Suggest Program, NCI Changes To Enhance Surgical Oncology

April 1, 1977